Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02411448 |
|---|---|
| Brief Title: | A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) (RELAY) |
| First Submitted : | April 3, 2015 |
| First Submitted that Met QC Criteria : | April 3, 2015 |
| First Posted : | April 8, 2015 (Estimate) |
| Results First Submitted : | January 17, 2020 |
| Results First Submitted that Met QC Criteria : | February 18, 2020 |
| Results First Posted : | March 4, 2020 |
| Last Update Submitted that Met QC Criteria : | March 15, 2024 |
| Last Update Posted : | March 18, 2024 |